EPIZYME INC's ticker is EPZM and the CUSIP is 29428V104. A total of 96 filers reported holding EPIZYME INC in Q2 2022. The put-call ratio across all filers is 5.75 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $28,000 | -91.7% | 24,475 | -81.9% | 0.00% | – |
| Q4 2021 | $337,000 | +0.6% | 134,924 | +106.1% | 0.00% | – |
| Q3 2021 | $335,000 | -30.1% | 65,453 | +13.6% | 0.00% | – |
| Q2 2021 | $479,000 | +40.1% | 57,622 | +46.7% | 0.00% | – |
| Q1 2021 | $342,000 | +33.6% | 39,290 | +66.4% | 0.00% | – |
| Q4 2020 | $256,000 | +18.0% | 23,612 | +29.6% | 0.00% | – |
| Q3 2020 | $217,000 | -73.0% | 18,218 | -63.6% | 0.00% | -100.0% |
| Q2 2020 | $804,000 | -27.7% | 50,049 | -30.2% | 0.00% | 0.0% |
| Q1 2020 | $1,112,000 | -37.9% | 71,723 | -1.5% | 0.00% | 0.0% |
| Q4 2019 | $1,791,000 | – | 72,823 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 9,166,667 | $109,358,000 | 16.39% |
| Burrage Capital Management LLC | 1,002,528 | $11,960,000 | 9.44% |
| Foresite Capital Management III, LLC | 998,278 | $11,909,000 | 8.87% |
| MPM BioImpact LLC | 2,854,737 | $34,057,000 | 8.20% |
| Palo Alto Investors LP | 6,403,600 | $76,395,000 | 4.19% |
| Foresite Capital Management II, LLC | 862,402 | $10,288,000 | 2.24% |
| Redmile Group, LLC | 8,311,633 | $99,158,000 | 1.82% |
| Pier Capital, LLC | 574,299 | $6,851,000 | 1.00% |
| Foresite Capital Management I, LLC | 243,759 | $2,908,000 | 0.82% |
| Rock Springs Capital Management LP | 2,551,659 | $30,441,000 | 0.77% |